NCI Restructures Communications

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 7
Volume 9
Issue 7

BETHESDA, Md-A major restructuring of the National Cancer Institute’s communications has combined and expanded the activities of four of the institute’s former offices. Susan Sieber, PhD, recently named the institute’s deputy director for communications, will head the new Office of Communications.

BETHESDA, Md—A major restructuring of the National Cancer Institute’s communications has combined and expanded the activities of four of the institute’s former offices. Susan Sieber, PhD, recently named the institute’s deputy director for communications, will head the new Office of Communications.

The restructuring creates five offices within the Office of Communications: cancer information products and systems, outreach and partnerships, media and public communications, technologies and services, and the communications coordination program.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Related Content